These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 3669762

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Primary treatment of hairy cell leukemia with low-dose human recombinant interferon-alpha-2c (Hr-IFn alpha 2c) in comparison with therapy following splenectomy. Interferon (IFn-alpha 2c) in HCL before or after splenectomy].
    Pralle H, Zwingers T, Boedewadt S, Bross K, Dörken B, Gamm H, Ho AD, Parwaresch RM, Schmitz N, Papendick U.
    Onkologie; 1987 Feb; 10(1):5-10. PubMed ID: 3295625
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Combination treatment of 2-chlorodeoxyadenosine and type I interferon on hairy cell leukemia-like cells: cytotoxic effect and MHC-unrestricted killer cell regulation.
    Reiter Z, Tomson S, Ozes ON, Taylor MW.
    Blood; 1993 Apr 01; 81(7):1699-708. PubMed ID: 8096405
    [Abstract] [Full Text] [Related]

  • 25. Interleukin 2 protects hairy leukemic cells from lymphokine-activated killer cell-mediated cytotoxicity.
    Reiter Z, Taylor MW.
    Cancer Res; 1993 Aug 01; 53(15):3555-60. PubMed ID: 7687924
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The U.K. experience with human lymphoblastoid interferon in HCL: a report of the first 50 cases.
    Worman CP, Catovsky D, Cawley JC, Bevan PC, Bottomley JM, Nethersell AB.
    Leukemia; 1987 Apr 01; 1(4):320-2. PubMed ID: 3669754
    [Abstract] [Full Text] [Related]

  • 31. Hairy cells possess more interferon receptors than other lymphoid cell types.
    Dadmarz R, Evans T, Secher D, Marshall N, Cawley JC.
    Leukemia; 1987 Apr 01; 1(4):357-61. PubMed ID: 2959825
    [Abstract] [Full Text] [Related]

  • 32. Changes in hairy cells after alpha-interferon treatment as measured by flow cytometry.
    Huang AT, Mold NG.
    Leukemia; 1987 Apr 01; 1(4):308-11. PubMed ID: 3669751
    [Abstract] [Full Text] [Related]

  • 33. Hairy cell leukemia: an interferon deficient disease?
    Hofmann V, Fehr J, Sauter C, Ottino J.
    Cancer Treat Rev; 1985 Dec 01; 12 Suppl B():33-7. PubMed ID: 3833328
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Successful treatment of T-hairy cell leukemia with lymphoblastoid-interferon.
    Rossi E, Gualandi F, Lamparelli T, Repetto M, Nocera A, Spriano M, Occhini D, Ruggeri C, Vimercati R, Damasio EE.
    J Exp Pathol; 1987 Dec 01; 3(4):593-601. PubMed ID: 3502652
    [No Abstract] [Full Text] [Related]

  • 36. Alpha interferon for induction of remission in hairy-cell leukemia.
    Quesada JR, Reuben J, Manning JT, Hersh EM, Gutterman JU.
    N Engl J Med; 1984 Jan 05; 310(1):15-8. PubMed ID: 6689734
    [Abstract] [Full Text] [Related]

  • 37. [Results of a multicenter study of the efficacy of recombinant alpha-2c interferon in hairy cell leukemia].
    Werter MJ, Bogman MJ, Janssen JT, de Pauw BE, Haanen CA.
    Ned Tijdschr Geneeskd; 1987 Nov 14; 131(46):2081-5. PubMed ID: 3683637
    [No Abstract] [Full Text] [Related]

  • 38. In vitro induction of proteins by alpha-interferon in hairy cell leukemia.
    Samuels BL, Golomb HM, Brownstein BH.
    Cancer Res; 1986 Aug 14; 46(8):4151-5. PubMed ID: 3731082
    [Abstract] [Full Text] [Related]

  • 39. Hematologic and immunologic changes in hairy cell leukemia patients treated with alpha interferon.
    Turhan AG, Eaves CJ, Connors JM, Eaves AC, Karim KA, Silver KB.
    J Biol Regul Homeost Agents; 1988 Aug 14; 2(4):157-65. PubMed ID: 2907963
    [Abstract] [Full Text] [Related]

  • 40. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
    Ozer H, Gavigan M, O'Malley J, Thompson D, Dadey B, Nussbaum-Blumenson A, Snider C, Rudnick S, Ferraresi R, Norred S.
    J Biol Response Mod; 1983 Aug 14; 2(6):499-515. PubMed ID: 6607323
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.